Literature DB >> 11846982

The role of IRF-4 in B and T cell activation and differentiation.

Alessandra B Pernis1.   

Abstract

Appropriate activation and differentiation of lymphocytes are critical for effective immune responses. These processes are normally guided by exposure of lymphocytes to different stimuli, which need to be appropriately integrated in order for lymphocytes to proceed along their activation and differentiation pathways. Although the early steps in lymphocyte activation have been studied extensively, the downstream effectors of these activation pathways and the basic mechanisms employed by lymphocytes to integrate the information provided by different activation stimuli are not fully characterized. Interferon (IFN) regulatory factor-4 (IRF-4) is a recently described member of the IRF family of transcription factors whose expression is largely restricted to lymphocytes. Genetic studies have indicated that IRF-4 is critical for the function of mature T and B cells. Here we review the role of IRF-4 as a downstream effector and potentially an integrator of lymphocyte responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846982     DOI: 10.1089/107999002753452728

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  18 in total

1.  Epigenetics of human T cells during the G0-->G1 transition.

Authors:  Alexander E Smith; Constantinos Chronis; Manolis Christodoulakis; Stephen J Orr; Nicholas C Lea; Natalie A Twine; Akshay Bhinge; Ghulam J Mufti; N Shaun B Thomas
Journal:  Genome Res       Date:  2009-06-22       Impact factor: 9.043

Review 2.  IL-4: an important cytokine in determining the fate of T cells.

Authors:  J L Silva-Filho; C Caruso-Neves; A A S Pinheiro
Journal:  Biophys Rev       Date:  2014-01-09

Review 3.  Complex interactions of transcription factors in mediating cytokine biology in T cells.

Authors:  Peng Li; Rosanne Spolski; Wei Liao; Warren J Leonard
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

Review 4.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

5.  IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.

Authors:  Juan Carlos Ramos; Phillip Ruiz; Lee Ratner; Isildinha M Reis; Carlos Brites; Celia Pedroso; Gerald E Byrne; Ngoc L Toomey; Valentine Andela; Edward W Harhaj; Izidore S Lossos; William J Harrington
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

Review 6.  IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?

Authors:  Partha S Biswas; Govind Bhagat; Alessandra B Pernis
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

7.  Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

Review 8.  IRF4: Immunity. Malignancy! Therapy?

Authors:  Arthur L Shaffer; N C Tolga Emre; Paul B Romesser; Louis M Staudt
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

9.  BATF-JUN is critical for IRF4-mediated transcription in T cells.

Authors:  Peng Li; Rosanne Spolski; Wei Liao; Lu Wang; Theresa L Murphy; Kenneth M Murphy; Warren J Leonard
Journal:  Nature       Date:  2012-09-19       Impact factor: 49.962

10.  Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.

Authors:  Antonio Martinez; Stefania Pittaluga; Martina Rudelius; Theresa Davies-Hill; Denise Sebasigari; Thomas J Fountaine; Stephen Hewitt; Elaine S Jaffe; Mark Raffeld
Journal:  Am J Surg Pathol       Date:  2008-08       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.